Carmichael Hill & Associates, Inc. Corbus Pharmaceuticals Holdings, Inc. Transaction History

Carmichael Hill & Associates, Inc.

  • $279 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 28, 2021
BUY
$1.27 - $3.42 $2,540 - $6,840
2,000 Added 200.0%
3,000 $6,000
Q4 2019

Jan 30, 2020
BUY
$4.29 - $5.64 $4,290 - $5,640
1,000 New
1,000 $5,000

Others Institutions Holding CRBP

# of Institutions
4
Shares Held
38.7K
Call Options Held
0
Put Options Held
0
View Full List

About Corbus Pharmaceuticals Holdings, Inc.

CRBP Quotes by TradingView
  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $2.08B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Carmichael Hill & Associates, Inc. Portfolio

Follow Carmichael Hill & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email